Skip to Content


In the US, Odomzo (sonidegib systemic) is a member of the drug class hedgehog pathway inhibitors and is used to treat Basal Cell Carcinoma.

US matches:

Ingredient matches for Odomzo


Sonidegib is reported as an ingredient of Odomzo in the following countries:

  • Switzerland
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.